Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 263,673Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 1Afinitor

02 9Afinitor/Votubia

03 1Everolimus Stent Drug

04 2Everolimus stent drug

05 1Zortress

06 8Zortress/Certican

PharmaCompass

01

Brand Name : Zortress/Certican

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Zortress/Certican

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Immunology

Currency : USD

2020 Revenue in Millions : 452

2019 Revenue in Millions : 485

Growth (%) : -7

blank

02

Brand Name : Afinitor/Votubia

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Afinitor/Votubia

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Oncology

Currency : USD

2020 Revenue in Millions : 1,083

2019 Revenue in Millions : 1,539

Growth (%) : -30

blank

03

Brand Name : Zortress/Certican

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Zortress/Certican

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Immunology

Currency : USD

2021 Revenue in Millions : 431

2020 Revenue in Millions : 452

Growth (%) : -5

blank

04

Brand Name : Afinitor/Votubia

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Afinitor/Votubia

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Oncology

Currency : USD

2021 Revenue in Millions : 938

2020 Revenue in Millions : 1,083

Growth (%) : -13

blank

05

Brand Name : Zortress/Certican

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Zortress/Certican

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Immunology

Currency : USD

2022 Revenue in Millions : 329

2021 Revenue in Millions : 431

Growth (%) : -24

blank

06

Brand Name : Afinitor/Votubia

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Afinitor/Votubia

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Oncology

Currency : USD

2022 Revenue in Millions : 512

2021 Revenue in Millions : 938

Growth (%) : -45

blank

07

Brand Name : Afinitor/Votubia

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Afinitor/Votubia

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 408

2022 Revenue in Millions : 512

Growth (%) : -20

blank

08

Brand Name : Afinitor

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Afinitor

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Oncology

Currency : USD

2014 Revenue in Millions : 20.30%

2013 Revenue in Millions :

Growth (%) :

blank

09

Brand Name : Zortress

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Zortress

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2014 Revenue in Millions : 31.30%

2013 Revenue in Millions :

Growth (%) :

blank

10

Brand Name : Everolimus stent drug

Everolimus

arrow
Pharmtech & Ingredients
Not Confirmed

Brand Name : Everolimus stent drug

arrow
Pharmtech & Ingredients
Not Confirmed

Everolimus

Main Therapeutic Indication : Immunology (Organ Transplant, Arthr...

Currency : USD

2014 Revenue in Millions : -17.00%

2013 Revenue in Millions :

Growth (%) :

blank